Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Annali Dell'Istituto Superiore Di Sanita|February 24, 2001
[Tissue-typing laboratories for organ transplantation]D Adorno, D Maccarone, F PapolaTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 9, 2020
Thewithdrawal of consent to haematopoietic stem cells (HSC) donation: The complicated balance between donor's rights and patient's protectionO Iuliani, C Passeri, F Papola, et al.Journal of Chemotherapy (Florence, Italy)|November 20, 1998
p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluationT Cutilli, F Papola, P Di Emidio, et al.Minerva Stomatologica|May 6, 1998
[p53 mutation and chemoresistance in oral-maxillofacial squamous cell carcinoma. Role of p53 in the cell cycle control and in the modulating action of chemotherapeutic agents]T Cutilli, F Papola, P Di Emidio, et al.Tissue Antigens|November 15, 2007
Identification of a novel HLA-B allele, HLA-B*3580, with possible implication in transplantation and CTL responseA Aureli, G Liberatore, F Papola, et al.Tissue Antigens|May 8, 2013
Identification of the novel HLA-B*50:18 allele variant in an Italian unrelated bone marrow donorR Azzarone, A Canossi, C Cervelli, et al.Tissue Antigens|January 11, 2011
Sequence-based typing identification of the novel HLA-A*24:135 variant in a Maldivian family with a bone marrow patientC Cervelli, A Canossi, R Azzarone, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|July 30, 1983
[Specific antibodies against lymphocytes and monocytes in multiple-transfused uremic patients]N Torlone, R Rosati, F Papola, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|October 30, 1983
[Separation of monocytes and their use in a cytotoxicity test]R Rosati, N Torlone, F Papola, et al.Minerva Stomatologica|May 14, 1998
[p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment]T Cutilli, F Papola, P Di Emidio, et al.Pageof 4